The research, conducted by the Arctic University of Norway (UiT), found that the risk of breast, ovarian, and uterine cancer decreases by approximately 10 percent with each childbirth. Women who have ...

HR+/HER2- 是乳腺癌中最常见的分子亚型 1。虽然 CDK4/6 抑制剂联合内分泌治疗已成为 HR+/HER2- 晚期乳腺癌的一线标准治疗 2，但患者仍难逃「耐药」的魔咒。在中关村精准医学基金会和丁香园联合发起的 2025 ...